Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study

American Journal of Medicine

Volumn 101, Issue 2, 1996, Pages 170-176

  Anaissie, Elias J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; DRUG TOXICITY; FEMALE; FEVER; HUMAN; HYPOKALEMIA; LIVER TOXICITY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0242437957     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)80072-6     Document Type: Article

References (2)

1. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992;29(suppl.A):19-24.
2. Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642-2645.